semaglutide shortage update FDA: Novo Nordisk's Ozempic and Wegovy, long in shortage, now available FDA says shortage of Ozempic

Looking from 2023 to 2024, the latest year of data available, prescriptions and gross spending for Wegovy (first approved for obesity in 2021, approved for cardiovascular disease in 2024) and Mounjaro (approved for type 2 diabetes in 2022) more than doubled, and prescriptions and gross spending for Zepbound (first approved for obesity in 2023, approved for sleep apnea in 2024) increased more than fivefold

JAMA Health Forum (2025): Showed that the cost per quality adjusted life year (QALY) for tirzepatide (Zepbound) was $197K and the cost per QALY for semaglutide (Wegovy) was $468K

If we approve your treatment, we'll also explain how to use the medication properly, what side effects to watch for, and how to get in touch if you have any concerns during your treatment. Ian Budd, Prescriber, Clinical Lead & Weight Loss Specialist Mounjaro treatment starts at a low dose that gradually increases over time this is called titration

Battisti, C

Asked about GLP-1 adoption and food consumption, CEO Alejandro Rodrguez Bas didnt hedge

As such, they are typically prohibited for high-level amateur and professional athletes